Stay updated on FG-3019 in Diabetic Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.

Latest updates to the FG-3019 in Diabetic Kidney Disease Clinical Trial page
- Check3 days agoChange DetectedThe footer’s site revision changed from v3.7.1 to v3.7.2, while the page remains a 403 error screen.SummaryDifference0.2%

- Check10 days agoChange DetectedThe site revision label in the footer changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRelevant study descriptors and history entries have been removed from the record, including the investigational drug pamrevlumab (FG-3019) and several disease/condition terms related to diabetes and kidney disease, along with administrative dates. This alters how the study is categorized and surfaced in the registry, affecting searchability and interpretation by users.SummaryDifference17%

- Check31 days agoChange DetectedThe page revision has been updated from v3.6.6 to v3.7.0, indicating a new version of the study page was published.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.6.6 has been added on the page, signaling a software version update for the study page. This update does not modify trial details, eligibility criteria, or locations.SummaryDifference0.1%

- Check74 days agoChange DetectedThe revision tag on the page updated from v3.6.4 to v3.6.5, representing a minor software version update. This change signals an updated build of the page but does not modify the study information presented.SummaryDifference0.0%

Stay in the know with updates to FG-3019 in Diabetic Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.